We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.


Accelerating mRNA-Based Therapy Development

Accelerating mRNA-Based Therapy Development content piece image

The diversity of potential mRNA-based therapies has led to increased interest in using synthetic mRNA as a tool in the treatment of multiple diseases. Nevertheless, obtaining larger quantities of synthetic mRNA for clinical treatment remains a challenge. Current mRNA production methods require multiple purification steps and various chemicals, thereby creating a bottleneck for large-scale manufacturing of in vitro transcribed (IVT) mRNA. To overcome these challenges, a new affinity chromatography resin for the isolation and purification of mRNA was developed.

Download this poster to discover a solution that will:

  • Simplify your mRNA downstream process
  • Increase purity and yield
  • Allow for scalable mRNA purification process without the use of toxic chemicals